Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.
Jan, 14 2026
Jan, 3 2026
Oct, 9 2025
Jan, 6 2026
Sep, 23 2025